Lundbeck
HLUN-B.CO
#2596
Rank
โ‚ฌ5.69 B
Marketcap
6,00ย โ‚ฌ
Share price
0.63%
Change (1 day)
4.20%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): 0,54ย โ‚ฌ

According to Lundbeck's latest financial reports the company's current EPS (TTM) is 0,53ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of 0,38ย โ‚ฌ an increase over its 2023 EPS that were of 0,29ย โ‚ฌ.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)0,54ย โ‚ฌ41.84%
20240,38ย โ‚ฌ29.29%
20230,29ย โ‚ฌ23.09%
20220,24ย โ‚ฌ37.26%
20210,17ย โ‚ฌ-84.61%
20201,13ย โ‚ฌ-24.61%
20191,50ย โ‚ฌ-42.06%
20182,59ย โ‚ฌ40.7%
20171,84ย โ‚ฌ146.26%
20160,75ย โ‚ฌ-120.48%
2015-3,65ย โ‚ฌ3231.32%
2014-0,11ย โ‚ฌ-115.78%
20130,69ย โ‚ฌ-23.36%
20120,90ย โ‚ฌ-48.01%
20111,74ย โ‚ฌ-9.68%
20101,93ย โ‚ฌ13.72%
20091,69ย โ‚ฌ24.32%
20081,36ย โ‚ฌ-6.05%
20071,45ย โ‚ฌ81.77%
20060,80ย โ‚ฌ-16.76%
20050,96ย โ‚ฌ-17.58%
20041,16ย โ‚ฌ